Latest AI and machine learning research in brain cancer for healthcare professionals.
Gliomas represent a highly aggressive class of tumors located in the brain. Despite the availability of multiple treatment modalities, the prognosis for patients diagnosed with glioma remains unfavorable. Therefore, further exploration of new biomarkers is crucial to enhance the prognostic assessment of glioma and to investigate more effective treatment options. In this research, we utilized multi...
Glioblastoma (GBM) is the most malignant brain cancer and one of the leading causes of cancer-related death globally. So, identifying potential molecular signatures and associated drug molecules are crucial for diagnosis and therapies of GBM. This study suggested GBM-causing ten key genes (ASPM, CCNB2, CDK1, AURKA, TOP2A, CHEK1, CDCA8, SMC4, MCM10, and RAD51AP1) from nine transcriptomics datasets ...
BACKGROUND AND PURPOSE: Glioblastoma is a highly aggressive brain tumor with limited survival that poses challenges in predicting patient outcomes. Th...
BACKGROUND AND PURPOSE: To describe the clinical commissioning of an in-house artificial intelligence (AI) treatment planning platform for head-and-ne...
Radiotherapy has been demonstrated to be one of the most significant treatments for cervical cancer, during which accurate and efficient delineation o...
OBJECTIVE: The purpose of this study was to compare radiation dose reduction capability for accurate liver tumor measurements of a computer-aided volu...
Reporting of diagnostic nuclear images in clinical cancer management is generally qualitative. Theranostic treatment with Lu radioligands for prostate...
Early and precise diagnosis of craniosynostosis (CSO), which involves premature fusion of cranial sutures in infants, is crucial for effective treatme...
OBJECTIVES: To evaluate the diagnostic accuracy of machine learning models incorporating multimodal features for predicting radiation pneumonitis in l...
Detecting brain tumors early on is critical for effective treatment and life-saving efforts. The analysis of the brain with MRI scans is fundamental t...
OBJECTIVE: Glioblastoma (GBM), one of the most common brain tumors, is known for its low survival rates and poor treatment responses. This study aims ...
Environmental complaints serve as a crucial means for citizens to participate in environmental regulation, providing precise insights for real-time id...
PURPOSE: To evaluate the value of pre-treatment MRI-based radiomics in patients with hepatocellular carcinoma (HCC) for the prediction of response to ...
BACKGROUND: Glioma is a highly heterogeneous and poorly immunogenic malignant tumor, with limited efficacy of immunotherapy. The characteristics of th...
Primary Central Nervous System tumors in the brain are among the most aggressive diseases affecting humans. Early detection and classification of brai...
The SINFONIA project's main objective is to develop novel methodologies and tools that will provide a comprehensive risk appraisal for detrimental eff...
Glioblastoma multiforme (GBM) is one of the most common and aggressive type of malignant glioma with an average survival time of 12-18 mo. Despite the...
INTRODUCTION: - Accurate detection, segmentation, and volumetric analysis of brain lesions are essential in neuro-oncology. Artificial intelligence (A...
Breast cancer poses a significant health threat to women, necessitating advancements in diagnostic technologies. Breast dynamic optical imaging (DOI) ...
OBJECTIVES: To evaluate the value of a magnetic resonance imaging (MRI)-based deep learning radiomic nomogram (DLRN) for distinguishing intracranial s...